Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Nature Medicine

Volumn 8, Issue 8, 2002, Pages 793-800

  Dong, Haidong ^a   Strome, Scott E ^a   Salomao, Diva R ^a   Tamura, Hideto ^a   Hirano, Fumiya ^a   Flies, Dallas B ^a   Roche, Patrick C ^a   Lu, Jun ^a   Zhu, Gefeng ^a   Tamada, Koji ^a   Lennon, Vanda A ^a   Cells, Esteban ^a   Chen, Lieping ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA B7 ANTIGEN; HLA B7 H1 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LUNG CARCINOMA; MELANOMA; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD PROTEINS; CELL SEPARATION; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; NEOPLASMS; PEPTIDES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR ESCAPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18544380239     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm730     Document Type: Article

References (39)

1. Co-stimulation in T cell responses
2. CD28/B7 system of T cell costimulation
3. Costimulation of T cells for tumor immunity
4. CD28 and apoptosis
5. T cell co-stimulatory molecules other than CD28
6. CD28 costimulation prevents cell death during primary T cell activation
7. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
8. 4-1BB is a bona fide CD8 T cell survival signal
9. + T cells
10. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
11. CTLA-4 ligation blocks CD28-dependent T cell activation
12. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
13. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function
14. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
15. Development of lupuslike autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
16. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
17. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
18. The Fas death factor
19. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
20. Functional expression of TRAIL by lymphoid and myeloid tumour cells
21. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes
22. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand
23. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins
24. Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease
25. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
26. A fresh look at tumor immunosurveillance and immunotherapy
27. Fas ligand-induced apoptosis as a mechanism of immune privilege
28. Fas counter-attack: The best form of tumor defense?
29. Immune evasion by tumours: Involvement of the CD95 (APO-1/Fas) system and its clinical implications
30. Human melanoma cells do not express Fas (Apo-1/CD95) ligand
31. Gene transfer of Fas ligand induces tumor regression in vivo
32. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen, RCAS1
33. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
34. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
35. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
36. G The human PD-1 gene: Complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors
37. Immunoglobulin fusion protein as a tool for evaluation of T-cell costimulatory molecules
38. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen
39. CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity